(Q28259151)

English

Chronic obstructive pulmonary disease

scientific article (publication date: 7 April 2012)

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Chronic obstructive pulmonary disease (English)

0 references

chronic obstructive pulmonary disease

0 references

Marc Miravitlles

object named as

Marc Miravitlles

3

0 references

1

object named as

Marc Decramer

0 references

author name string

Wim Janssens

2

0 references

language of work or name

0 references

publication date

7 April 2012

0 references

0 references

379

0 references

9823

0 references

1341-51

0 references

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Global burden of COPD: risk factors, prevalence, and future trends

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in the leading causes of death in the United States, 1970-2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Global burden of COPD: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Early life origins of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A genome-wide association study of pulmonary function measures in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

MMP12, lung function, and COPD in high-risk populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathology of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

What drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

New paradigms in the pathogenesis of chronic obstructive pulmonary disease I.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics and genomics of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic aspects of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Innate immune recognition in infectious and noninfectious diseases of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic obstructive pulmonary disease: molecular and cellularmechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative stress and redox regulation of lung inflammation in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cigarette smoke-induced emphysema: A role for the B cell?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antielastin autoimmunity in tobacco smoking-induced emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

TH17 cells in asthma and COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Alveolar cell senescence in patients with pulmonary emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cigarette smoke induces senescence in alveolar epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

COPD as a disease of accelerated lung aging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of lung maintenance program in the heterogeneity of lung destruction in emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cells are dispensable for lung homeostasis but restore airways after injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Epithelial repair mechanisms in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between lung function and exacerbation frequency in patients with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Infection in the pathogenesis and course of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Variability and effects of bronchial colonisation in patients with moderate COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pseudomonas aeruginosa in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of antimicrobial treatment in mechanically ventilated patients with severe chronic obstructive pulmonary disease exacerbations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality of COPD Patients Infected with Multi-Resistant Pseudomonas aeruginosa: A Case and Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial infection in exacerbated COPD with changes in sputum characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory viral infection in exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Complex chronic comorbidities of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality in COPD: Role of comorbidities.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The problem of tobacco smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Waging war on modern chronic diseases: primary prevention through exercise biology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical Activity Transitions and Chronic Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

From COPD to chronic systemic inflammatory syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic effects of smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Raised CRP levels mark metabolic and functional impairment in advanced COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic manifestations and comorbidities of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Smoking and lung function of Lung Health Study participants after 11 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary rehabilitation for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary rehabilitation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of tiotropium on exacerbations and airflow in patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tiotropium HandiHaler in the treatment of COPD: a safety review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular safety of tiotropium in patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Safety of Tiotropium — The FDA's Conclusions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of COPD: the sooner the better?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung function and airway diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-morbidity in COPD: the effects of cardiovascular drug therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Azithromycin for prevention of exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Defective macrophage phagocytosis of bacteria in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucoactive therapy in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotics for exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunology of asthma and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Indacaterol maleate for the treatment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

CC-chemokine receptors in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The vitamin D axis in the lung: a key role for vitamin D-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Integrated care prevents hospitalisations for exacerbations in COPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960968-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic obstructive pulmonary disease surveillance--United States, 1971-2000

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0140-6736(11)60968-9

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28259151&oldid=1765244685"